Coverage Coverage February 22, 2022 Radiomics in Action The intersection of academic research and clinical trials. Many academic researchers and life sciences organizations are leveraging radiomics, which... Read More Coverage January 17, 2022 Radiomics: 3 Challenges That Must Be Solved Before Widespread Adoption Occurs Read what Robert Holmes, Chief Science Officer at HealthMyne, has to say about the challenges that must be solved... Read More Coverage January 4, 2022 Radiomics: The present and future of advanced imaging analytics Rose Higgins, CEO of HealthMyne shares her prediction for Pharma in 2022. Read how radiomics adoption continues to gain... Read More Coverage December 15, 2021 Drug Discovery & Development Rose Higgins, CEO of HealthMyne shares her prediction for Pharma in 2022. Read how radiomics adoption continues to gain... Read More Coverage December 15, 2021 Big Data, Analytics, and AI Could Take Center Stage in 2022 Hear our 2022 prediction for AI and Radiomics. Rose Higgins, CEO of HealthMyne joins other industry thought leaders to... Read More Coverage October 7, 2021 AI Insights: Personal Touch The science of genomics changed cancer research and treatment by giving clinicians the ability to understand how specific genes... Read More Coverage September 8, 2021 Radiomics-based patient inclusion model improves clinical trial performance Read the full published research on how HealthMyne’s radiomic solution was leveraged by a leading research organization to determine... Read More Coverage August 31, 2021 Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients HealthMyne was leveraged for lesion segmentation and automatic radiomic feature extraction. Identification of biomarkers allow for the appropriate stratification... Read More Coverage June 24, 2021 How Radiomics Delivers Greater Personalization to Cancer Treatment Advances in genomics have in recent years accelerated the personalization of medicine, but that was just the beginning. As researchers... Read More 123…5›
Coverage February 22, 2022 Radiomics in Action The intersection of academic research and clinical trials. Many academic researchers and life sciences organizations are leveraging radiomics, which... Read More
Coverage January 17, 2022 Radiomics: 3 Challenges That Must Be Solved Before Widespread Adoption Occurs Read what Robert Holmes, Chief Science Officer at HealthMyne, has to say about the challenges that must be solved... Read More
Coverage January 4, 2022 Radiomics: The present and future of advanced imaging analytics Rose Higgins, CEO of HealthMyne shares her prediction for Pharma in 2022. Read how radiomics adoption continues to gain... Read More
Coverage December 15, 2021 Drug Discovery & Development Rose Higgins, CEO of HealthMyne shares her prediction for Pharma in 2022. Read how radiomics adoption continues to gain... Read More
Coverage December 15, 2021 Big Data, Analytics, and AI Could Take Center Stage in 2022 Hear our 2022 prediction for AI and Radiomics. Rose Higgins, CEO of HealthMyne joins other industry thought leaders to... Read More
Coverage October 7, 2021 AI Insights: Personal Touch The science of genomics changed cancer research and treatment by giving clinicians the ability to understand how specific genes... Read More
Coverage September 8, 2021 Radiomics-based patient inclusion model improves clinical trial performance Read the full published research on how HealthMyne’s radiomic solution was leveraged by a leading research organization to determine... Read More
Coverage August 31, 2021 Preliminary Report on Computed Tomography Radiomics Features as Biomarkers to Immunotherapy Selection in Lung Adenocarcinoma Patients HealthMyne was leveraged for lesion segmentation and automatic radiomic feature extraction. Identification of biomarkers allow for the appropriate stratification... Read More
Coverage June 24, 2021 How Radiomics Delivers Greater Personalization to Cancer Treatment Advances in genomics have in recent years accelerated the personalization of medicine, but that was just the beginning. As researchers... Read More
